Persistent URL of this record https://hdl.handle.net/1887/110096
In Collections
This item can be found in the following collections:
A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease
- All authors
- Dotan, I.; Rachmilewitz, D.; Schreiber, S.; Eliakim, R.; Woude, C.J. van der; Kornbluth, A.; Buchman, A.L.; Bar-Meir, S.; Bokemeyer, B.; Goldin, E.; Maaser, C.; Mahadevan, U.; Seidler, U.; Hoffman, J.C.; Homoky, D.; Plasse, T.; Powers, B.; Rutgeerts, P.; Hommes, D.; Semapimod-CD04 CD05 Investigators
- Date
- 2010-06-30
- Journal
- Gut
- Volume
- 59
- Issue
- 6
- Pages
- 760 - 766